VemiCo Ltd

From gut microbiota to therapeutics via AI and synthetic biology

Based based in Europe, Middle East, and Africa (EMEA), VemiCo Ltd works in nutrition wellness, founded in 2018.

Profile

We address modern lifestyle diseases and conditions without the need to change person’s lifestyle, with a novel and unique technology that mimics the communication skills of certain beneficial members of the gut microbiome. We integrate sequencing/informatics technologies and synthetic biology to identify and advance promising molecules encoded in gut microbial DNA. Our developing platform allows us to identify, characterize and prioritize naturally occurring molecules for nutraceuticals application and further redesign them in silico providing practical access to numerous new potential drugs. Our aim is to create sustainable, cost effective and widely available therapies that improve sufferers’ outcomes. Read a little more about us here: https://www.nutraingredients.com/Article/2020/08/17/Gut-health-experts-bypass-microbiome-modulation-with-redesigned-supplements#

VemiCo Ltd is positioned in nutrition wellness, a segment that rewards a clear, focused offering.

Its base of operations is Europe, Middle East, and Africa (EMEA).

Directory data places it at the Seed stage.

Recorded headcount: 2-10 employees.

Public records show total funding of about $1K.

Website: vemico.co.uk